Full Text View
Tabular View
No Study Results Posted
Related Studies
Laser-Mediated Photodynamic Therapy of Acne Vulgaris and Rosacea
This study has been completed.
Study NCT00483145   Information provided by Bispebjerg Hospital
First Received: June 4, 2007   Last Updated: June 2, 2008   History of Changes

June 4, 2007
June 2, 2008
November 2006
 
 
 
Complete list of historical versions of study NCT00483145 on ClinicalTrials.gov Archive Site
 
 
 
Laser-Mediated Photodynamic Therapy of Acne Vulgaris and Rosacea
Laser-Mediated Photodynamic Therapy of Acne Vulgaris and Rosacea

To evaluate efficacy and adverse effect from long-pulsed dye laser versus long-pulsed dye laser-mediated photodynamic therapy for acne vulgaris and rosacea.

 
 
Interventional
Randomized, Single Blind, Active Control, Single Group Assignment
Acne Vulgaris and Rosacea
  • Device: Long-pulsed dye laser (Candela) and PDT (methylaminolevulinate)
  • Device: Long-pulsed dye laser
  • Device: Long-pulsed dye laser assisted fotodynamic therapy (methylaminolevulinate)
  • Active Comparator: Long-pulsed dye laser (Candela)
  • Active Comparator: Long-pulsed dye laser assisted fotodynamic therapy (methylaminolevulinate)
 

*   Includes publications given by the data provider as well as publications identified by National Clinical Trials Identifier (NCT ID) in Medline.
 
Completed
 
November 2007
 

Inclusion Criteria:

  • Inflammatory acne and rosacea
  • Skin types I-IV

Exclusion Criteria:

  • Patients younger than 18 years
  • Skin types V and VI
  • Topical and systemic conventional acne treatments
Both
18 Years and older
 
Contact information is only displayed when the study is recruiting subjects
Denmark
 
NCT00483145
Merete Hædersdal, Bispebjerg Hospital
KF-01-328309
Bispebjerg Hospital
 
Principal Investigator: Merete Hædersdal Bispebjerg Hospital
Bispebjerg Hospital
June 2008

ICMJE     Data element required by the International Committee of Medical Journal Editors and the World Health Organization ICTRP